EP Patent

EP3494106B1 — Processes for making, and methods of using, glycopyrronium compounds

Assigned to Journey Medical Corp · Expires 2022-07-20 · 4y expired

What this patent protects

Patent listed against glycopyrronium-tosylate.

Drugs covered by this patent

glycopyrronium-tosylate (GLYCOPYRRONIUM TOSYLATE)

Patent Metadata

Patent number: EP3494106B1
Jurisdiction: EP
Classification: —
Expires: 2022-07-20
Drug substance claim: No
Drug product claim: No
Assignee: Journey Medical Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.